Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cancer drug enters first human trials for Tough-to-Treat tumors

NCT ID NCT06816108

Recruiting now Disease control Sponsor: Ono Pharmaceutical Co. Ltd Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called ONO-7428 in people with advanced solid tumors that cannot be surgically removed or have returned after treatment. The main goal is to find the highest dose that patients can tolerate safely and understand how the drug behaves in the body. The trial is for patients whose cancer has not responded to standard therapies, including certain immunotherapy drugs they've already tried.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hyogo Medical University Hospital

    RECRUITING

    Nishinomiya, Hyōgo, Japan

  • Kanagawa Cancer Center

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Kansai Medical University Hospital

    RECRUITING

    Hirakata, Osaka, Japan

  • Kindai University Hospital

    RECRUITING

    Sakai, Osaka, Japan

  • Kitasato University Hospital

    RECRUITING

    Sagamihara, Kanagawa, Japan

  • Kochi Medical School Hospital

    RECRUITING

    Nankoku, Kochi, Japan

  • Kurume University Hospital

    RECRUITING

    Kurume, Fukuoka, Japan

  • Kyoto University Hospital

    RECRUITING

    Kyoto, Kyoto, Japan

  • Nagoya University Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, Chiba, Japan

  • Osaka International Cancer Institute

    RECRUITING

    Osaka, Osaka, Japan

  • Saitama Cancer Center

    RECRUITING

    Shinden, Saitama, Japan

  • Saitama Medical University International Medical Center

    RECRUITING

    Hidaka, Saitama, Japan

  • The Cancer Institute Hospital Of JFCR

    RECRUITING

    Koto-Ku, Tokyo, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

    RECRUITING

    Bunkyō-Ku, Tokyo, Japan

Conditions

Explore the condition pages connected to this study.

NSCLC SOLID TUMOR